Effect of DHEA on Patients With Poor Ovarian Responds (NCT02432248) | Clinical Trial Compass
UnknownNot Applicable
Effect of DHEA on Patients With Poor Ovarian Responds
China350 participantsStarted 2015-02
Plain-language summary
The purpose of this study is to investigate the effect of DHEA for treatment of subfertile patients with poor ovarian reserve and post-treatment evaluation of IVF outcome.
Who can participate
Age range21 Years – 42 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Indicated for IVF treatment according to our standard department protocol
* Age \< 42
* Regular menstrual cycles (21-35 days)
Poor ovarian responders are defined according to the Bologna criteria fulfilling 2 out of 3 of the following:
* Advanced maternal age (≥40) or any other genetic or acquired risk factor for POR
* Previous poor ovarian response (POR) (≤3 oocytes with a conventional stimulation protocol using at least 150IU gonadotrophins per day)
* Abnormal ovarian reserve test (i.e. AFC \< 5-7 or AMH \< 0.5-1.1ng/ml). Alternatively, two episodes of POR after maximal stimulation are sufficient to define a patient as poor responder in the absence of advanced maternal age or abnormal ORT.
Exclusion Criteria:
* Previous chemotherapy or pelvic irradiation
* Polycystic ovarian syndrome or polycystic ovaries
* On hormonal supplementation for any indication at the time of recruitment (e.g. estrogen, testosterone or DHEA)
What they're measuring
1
Live birth rate
Timeframe: Participants will be followed for live birth rate up to 1 year.
Trial details
NCT IDNCT02432248
SponsorThe Affiliated Hospital of Inner Mongolia Medical University